Global and China Attention Deficit Hyperactivity Disorder (ADHD) Market Size, Status and Forecast 2020-2026

Attention Deficit Hyperactivity Disorder (ADHD) is a brain disorder marked by an ongoing pattern of inattention and/or hyperactivity-impulsivity that interferes with functioning or development. It may begin in early childhood and can continue into adulthood. Without treatment, ADHD can cause problems at home, at school, at work, and with relationships. In the past, ADHD was termed as Attention Deficit Disorder (ADD). The exact cause is not known, but ADHD tends to run in families. Boys are about three times more likely than girls to be diagnosed with it.
For many people, ADHD medications reduce hyperactivity and impulsivity and improve their ability to focus, work, and learn. On the basis of medication the market size covers Stimulants (Amphetamine, Methylphenidate, Dextroamphetamine, Dexmethylphenidate, and Lisdexamfetamine Dimesylate): Stimulant is the most common type of medication used for treating ADHD. It increases the brain chemicals dopamine and norepinephrine, which play important roles in thinking and attention; Non-stimulants (Atomoxetine, Bupropion, Guanfacine, and Clonidine): These medications take longer to start working than stimulants, but can also improve focus, attention, and impulsivity in a person with ADHD. Although not approved by the U.S. Food and Drug Administration (FDA) specifically for the treatment of ADHD, some antidepressants are sometimes used alone or in combination with a stimulant to treat ADHD.

Market Analysis and Insights: Global Attention Deficit Hyperactivity Disorder (ADHD) Market
The global Attention Deficit Hyperactivity Disorder (ADHD) market size is projected to reach US$ 18440 million by 2026, from US$ 14890 million in 2020, at a CAGR of 3.6% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Attention Deficit Hyperactivity Disorder (ADHD) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Attention Deficit Hyperactivity Disorder (ADHD) market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Attention Deficit Hyperactivity Disorder (ADHD) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Attention Deficit Hyperactivity Disorder (ADHD) market.

Global Attention Deficit Hyperactivity Disorder (ADHD) Scope and Market Size
Attention Deficit Hyperactivity Disorder (ADHD) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Attention Deficit Hyperactivity Disorder (ADHD) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into

Stimulants
Non-Stimulants

Market segment by Application, split into

Specialty Clinics
Hospital
Retail

Based on regional and country-level analysis, the Attention Deficit Hyperactivity Disorder (ADHD) market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Attention Deficit Hyperactivity Disorder (ADHD) market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.

The key players covered in this study

Takeda
Neos Therapeutics
Eli Lilly
Pfizer
Alcobra
Supernus Pharmaceuticals
Noven Pharmaceuticals
Novartis
Johnson & Johnson
Curemark

Frequently Asked Questions